Cyclooxygenase-3: Axiom, dogma, anomaly, enigma or splice error? - Not as easy as 1, 2, 3

Journal of Pharmacy and Pharmaceutical Sciences

Volumn 7, Issue 2, 2004, Pages 217-226

  Davies, Neal M ^a   Good, Renee L ^a   Roupe, Kathryn A ^a   Yáñez, Jaime A ^a  

^a WASHINGTON STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CELECOXIB; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; CYCLOOXYGENASE 3; DICLOFENAC; ENZYME VARIANT; FLURBIPROFEN; IBUPROFEN; INDOMETACIN; MESSENGER RNA; NONSTEROID ANTIINFLAMMATORY AGENT; PARACETAMOL; PROSTAGLANDIN D2; PROSTAGLANDIN E2; SULINDAC; SULINDAC SULFONE; TOLFENAMIC ACID;

ALTERNATIVE RNA SPLICING; ANALGESIC ACTIVITY; ANTIINFLAMMATORY ACTIVITY; ANTIPYRETIC ACTIVITY; ARTICLE; COLORECTAL CANCER; CONCENTRATION RESPONSE; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG POTENCY; DRUG SAFETY; DRUG SELECTIVITY; DRUG SENSITIVITY; DRUG SPECIFICITY; DRUG TARGETING; ENZYME ACTIVITY; ENZYME INHIBITION; GENETIC VARIABILITY; HUMAN; NOMENCLATURE; NONHUMAN; PHARMACOGENETICS; PROSTAGLANDIN SYNTHESIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; SINGLE NUCLEOTIDE POLYMORPHISM;

ACETAMINOPHEN; ALTERNATIVE SPLICING; ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CYCLOOXYGENASE INHIBITORS; HUMANS; POLYMORPHISM, SINGLE NUCLEOTIDE; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES;

EID: 12844253982     PISSN: 14821826     EISSN: 14821826     Source Type: Journal    
DOI: None     Document Type: Article

References (55)

1. Vane, J.R. Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. Nat New Bio, 231(25):232-235, 1971.
2. Fu, J.Y., Masferrer, J.L., Seibert, K., Raz, A., Needleman, P. The induction and suppression of prostaglandin H2 synthase (cylooxygenase) in human monocytes. J Biol Chem, 265 (28):1727-1740, 1990.
3. Simon LS. COX-2 inhibitors. Are they nonsteroidal anti-inflammatory drugs with a better safety profile? Gastroenterol Clin North Am. 30:1011-1025, 2001.
4. Flower, R.J., Vane, J.R. Inhibition of prostaglandin synthetase in brain explains the anti-pyretic activity of paracetamol (4-acetamidophenol). Nature, 240(5381):410-13, 1972.
5. Simmons, D.L., Botting, R.M., Robertson, M., Madsen, M.L., Vane, J.R. Induction of an acetaminophen-sensitive cyclooxygenase with reduced sensitivity to nonsteroid antiinflammatory drugs. Proc Natl Acad Sci U S A, 96(6):3275-80,1999.
6. Chandrasekharan, N.V., Dai, H., Roos, K.L., Evanson, N.K., Tomsik, J., Elton, T.S., Simmons, D.L. COX-3, a cyclooxygenase-1 variant inhibited by acetaminophen and other analgesic/antipyretic drugs: cloning, structure, and expression. Proc Natl Acad Sci U S A, 99(21):13926-31, 2002.
7. Ouellet, M., Percival, M.D. Mechanism of acetaminophen inhibition of cyclooxygenase isoforms. Arch Biochem Biophys, 387(2):273-80, 2001.
8. Prescott, L.F., Paracetamol: past, present and future. Am J Ther, 7:143-147, 2000.
9. Graham, G.G., and Scott, K. F., Mechanisms of action of paracetamol and related analgesics. Inflammopharmacology, 11(4-6): 401-413, 2003.
10. Xie, W.L., Chipman, J.G., Robertson, D.L., Erikson, R.L., Simmons, D.L. Expression of a mitogen-responsive gene encoding prostaglandin synthase is regulated by mRNA splicing. Proc Natl Acad Sci U S A, 88:2692-2696, 1991.
11. Diaz, A., Reginato, A.M., Jimenez, S.A. Alternative splicing of human prostaglandin G/H synthase mRNA and evidence of differential regulation of the resulting transcripts by transforming growth factor beta 1, interleukin 1 beta, and tumor necrosis factor alpha. J Biol Chem, 267(15):10816-22, 1992.
12. DeWitt, D.L., Meade, E.A. Serum and glucocorticoid regulation of gene transcription and expression of the prostaglandin H synthase-1 and prostaglandin H synthase-2 isozymes. Arch Biochem Biophys, 306(1):94-102, 1993.
13. Kitzler, J., Hill, E., Hardman, R., Reddy, N., Philpot, R., Eling, T.E. Analysis and quantitation of splicing variants of the TPA-inducible PGHS-1 mRNA in rat tracheal epithelial cells. Arch Biochem Biophys, 316(2):856-63, 1995.
14. Plant, M.H., Laneuville, O. Characterization of a novel transcript of prostaglandin encloperoxide H synthase 1 with a tissue-specific profile of expression. Biochem J, 344:677-685, 1999.
15. Hla, T. Molecular characterization of the 5.2 KB iso-form of the human cyclooxygenase-1 transcript. Prostaglandins, 51(1):81-5. 1996.
16. Willoughby, D.A., Moore, A.R., Colville-Nash P.R. COX-1, COX-2 and COX-3 and the future treatment of chronic inflammatory disease. Lancet, 355(9204):646-648, 2000.
17. Botting, R.M. Mechanism of action of acetaminophen: is there a cyclooxygenase 3? Clin Infect Dis, 31 Suppl 5:S202-10, 2000.
18. Wickelgren, I. Enzyme might relieve headache. Science, 297(5589):1976, 2002
19. Bazan, N.G., Flower, R.J. Medicine: lipid signals in pain control. Nature, 420(6912):135-8, 2002.
20. Schwab, J.M., Schluesener H.J., Meyermann, R., Serhan, C.N. COX-3 the enzyme and the concept: steps towards highly specialized pathways and precision therapeutics? Prostaglandins Leukot Essent Fatty Acids, 69(5):339-43, 2003.
21. Schwab, J.M., Schluesener, H.J., Laufer, S. COX-3: just another COX or the solitary elusive target of paracetamol? Lancet, 361(9362):981-2, 2003.
22. Smith, A. Time for a new COX. Nature Reviews, 1:839, 2002.
23. Warner, T.D., Mitchell, J.A. Cyclooxygenase-3 (COX-3): filling in the gaps toward a COX continuum? Proc Natl Acad Sci U S A, 99(21):13371-3, 2002.
24. Warner, T.D., Mitchell, J.A. Cyclooxygenases: new forms, new inhibitors, and lessons from the clinic. FASEB J, 18:790-804, 2004.
25. van der Donk, W.A., Tsai, A.L., Kulmacz, R.J. The cyclooxygenase reaction mechanism. Biochemistry, 41:15451-15458, 2002.
26. Botting, R. COX-1 and COX-3 inhibitors. Thrombosis Research, 110:269-272, 2003.
27. Senior, K., Homing in on COX-3 - the elusive target of paracetamol. The Lancet, 1:399, November 2002.
28. Vogiagis, D., Glare, E.M., Misajon, A., Brown, W., O'Brien, P.E. Cyclooxygenase-1 and an alternatively spliced mRNA in the rat stomach: effects of aging and ulcers. Am J Physiol Gastrointest Liver Physiol, 278(5):G820-7, 2000.
29. Vogiagis, D., Brown, W., Glare, E.M., O'Brien, P.E. Rat colorectal tumours treated with a range of non-steroidal anti-inflammatory drugs show altered cyclooxygenase-2 and cyclooxygenase-1 splice variant mRNA expression levels. Carcinogenesis, 22(6):869-74, 2001.
30. Kis, B., Snipes, J.A., Isse, T., Nagy, K., Busija, D.W. Putative cyrclooxygenase-3 expression in rat brain cells. J Cereb, Blood Flow Metab, 23(11):1287-92, 2003.
31. Kis, B., Snipes, A., Bari, F., Busija, D.W. Regional distribution of cyclooxygenase-3 mRNA in the rat central nervous system. Brain Res Mol Brain Res, 126(1):78-80, 2004.
32. Warner, T.D., Vojnovic, I., Giuliano, F., Jiminez, R., Bishop-Bailey, D., Mitchell, J.A. Cyclooxygenases-1, 2 and 3 and the production of prostaglandin 12: investigating the activities of acetamiriophen and cyclooxygenase-2-selective inhibitors in rat tissues. J Pharmacol Exp Ther, In Press, May 17 2004 [Epub ahead of print] PMID: 15148345 [PubMed - as supplied by publisher].
33. Shaftel, S.S., Olschowka, J.A., Hurley, S.D., Moore, A.H., O'Banion, M.K. COX-3: a splice variant of cyclooxygenase-1 in mouse neural tissue and cells. Brain Res Mol Brain Res, 119(2):213-5, Nov 26 2003.
34. Gryglewski, R.J., Swies, J., Uracz, W., Chlopicki, S., Marcinkiewicz, E. Mechanisms of anglotensin-converting enzyme inhibitor induced thrombolysis in Wistar rats. Thromb Res, 110(5-6):323-9, 2003.
35. Laudanno, O.M., San MigVel, P., Aramberry, L.J., Cesolari, J.A. Mechanism of inhibition Of COX-2 and COX-3 in gastrointestinal damage induced by NSAID in rats. Acta Gastroenterol Latinoam, 33(4):183-5, 2003.
36. Gilroy, D.W. Inducible cyclooxygenase may have anti-inflammatory properties. Nat Med, 5(6):698-701, 1999.
37. Serhan, C.N., Hong, S., Gronert, K., Colgan, S.P., Devchand, P.R., Mirick, G., Moussignac, R.L. Resolvins: a family of bioactive products of omega-3 fatty acid transformation circuits initiated by aspirin treatment that counter proinflammation signals. J Exp Med, 196(8):1025-37, 2002.
38. Serhan, C.N. Lipoxins and aspirin-triggered 15-epilipoxin biosynthesis: an update and role in anti-inflammation and pro-resolution. Prostaglandins Other Lipid Mediat., 68-69:433-55, 2002.
39. Fritsche, E., Baek, S.J., King, L.M., Zeldin, D.C., Eling, T.E., Bell, D.A. Functional characterization of cyclooxygenase-2 polymorphisms. J Pharmacol Exp Ther, 299(2):468-76, 2001.
40. Halushka, M.K., Walker, L.P., Halushka, P.V. Genetic variation in cyclooxygenase 1: effects on response to aspirin. Clin Pharmacol Ther, 73(1):122-30, Jan 2003.
41. Ulrich, C.M., Bigler, J., Sibert, J., Greene, E.A., Sparks, R., Carlson, C.S., Potter, J.D. Cyclooxygenase 1 (COX1) polymorphisms in African-American and Caucasian populations. Hum Mutat, 20(5):409-10, 2002.
42. Humar, B., Giovanoli, 0., Wolf, A., Attenhofer, M., Benclik, I., Meier, R., Muller, H., Dobbie, Z. Germline alterations in the cyclooxygenase-2 gene are not associated with the development of extracolonic manifestations in a large swiss familial adenomatous polyposis kindred. Int J Cancer, 87(6):812-7, 2000.
43. Spirio, L.N., Dixon, D.A., Robertson, J., Robertson, M., Barrows, J., Traer, E., Burt, R.W., Leppert, M.F., White, R., Prescott, S.M. The inducible prostaglandin biosynthetic enzyme, cyclooxygenase 2, is not mutated in patients with attenuated adenomatous polyposis coli. Cancer Res, 58(21):4909-12, 1998.
44. Ulrich, C.M., Bigler, J., Sparks, R., Whitton, J., Sibert, J.G., Goode, E.L., Yasui, Y., Potter, J.D. Polymorphisms in PTGS1 (=COX-1) and risk of colorectal polyps. Cancer Epidemiol Biomarkers Prev, 13(5):889-93, 2004.
45. Dore, M., Cote, L.C., Mitchell, A., Sirois, J. Expression of prostaglandin G/H synthase type 1, but not type 2, in human ovarian adenocarcinomas. J Histochem Cytochem, 46(1):77-84, 1998.
46. Sales, K.J., Katz, A.A., Howard, B., Soeters, R.P., Millar, R.P., Jabbour, H.N., Soeters, R.P. Cyclooxygenase-1 is up-regulated in cervical carcinomas: autocrine/paracrine regulation of cyclooxygenase-2, prostaglandin e receptors, and angiogenic factors by cyclooxygenase-1. Cancer Res, 62(2):424-32, 2002.
47. Rocca, B., Morosetti, R., Habib, A., Maggiano, N., Zassadowski, F., Ciabattoni, G., Chomienne, C., Papp, B., Ranelletti, F.O. Cyclooxygenase-1, but not -2, is upregulated in NB4 leukemic cells and human primary promyelocytic blasts during differentiation. Leukemia, 1-4, 2004.
48. Li, S., Wang, Y., Matsumura, K., Ballou, L.R., Morham, S.G., Blatteis, C.M. The febrile response to lipopolysaccharide is blocked in cyclooxygenase-2(-/-), but not in cyclooxygenase-l(-/-) mice. Brain Res, 825(1-2):86-94, 1999.
49. Schwartz, J.I., Chan, C.C., Mukhopadhyay, S., McBride, K.J., Jones, T.M., Adcock, S., Moritz, C., Hedges, J., Grasing, K., Dobratz, D., Cohen, R.A., Davidson, M.H., Bachmann, K.A., Gertz, B.J. Cyclooxygenase-2 inhibition by rofecoxib reverses naturally occurring fever in humans. Clin Pharmacol Ther, 65(6):653-60, 1999.
50. Schwab, J.M., Schluesener, H.J. Cyclooygenases and central nervous system inflammation: concenptual neglect of cylooxygenase 1. Arch Neurol, 60(4):630-632, 2003.
51. Schwab, J.M., Beiter, T., Linder, J.U., Laufer, S., Schulz, J.E., Meyermann, R., Schluesener, H.J. COX-3 - a virtual pain target in humans? FASEB J, 17(15):2174-5, 2003.
52. Zhu, X., Conklin, D., Eisenach, J.C. Cyclooxygenase-1 in the spinal cord plays an important role in postoperative pain. Pain, 104(1-2):15-23, 2003.
53. Davies, N.M., Sharkey, K.A., Asfaha, S., Macnaughton, W.K., Wallace, J.L. Aspirin causes rapid up-regulation of cyclo-oxygenase-2 expression in the stomach of rats. Aliment Pharmacol Ther, 11(6):1101-8, 1997.
54. Dinchuck, J.E., Liu, R.Q., Trzaskos, J.M. COX-3 in the wrong frame in mind. Immunology Letter, 86(9):121, 2003.
55. Simmons, D.L. Variants of cylooxygenase-1 and their roles in medicine. Thrombosis Research, 110:265-268, 2003.